- Home
- YMAB vs KFS Comparison
YMAB vs KFS Comparison
Compare YMAB & KFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- KFS
- Stock Information
- Founded
- YMAB 2015
- KFS 1989
- Country
- YMAB United States
- KFS United States
- Employees
- YMAB N/A
- KFS N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- KFS Property-Casualty Insurers
- Sector
- YMAB Health Care
- KFS Finance
- Exchange
- YMAB Nasdaq
- KFS Nasdaq
- Market Cap
- YMAB 218.4M
- KFS 220.3M
- IPO Year
- YMAB 2018
- KFS 1996
- Fundamental
- Price
- YMAB $4.69
- KFS $8.09
- Analyst Decision
- YMAB Buy
- KFS
- Analyst Count
- YMAB 11
- KFS 0
- Target Price
- YMAB $18.73
- KFS N/A
- AVG Volume (30 Days)
- YMAB 318.1K
- KFS 109.1K
- Earning Date
- YMAB 05-06-2025
- KFS 05-07-2025
- Dividend Yield
- YMAB N/A
- KFS N/A
- EPS Growth
- YMAB N/A
- KFS N/A
- EPS
- YMAB N/A
- KFS N/A
- Revenue
- YMAB $87,685,000.00
- KFS $112,710,000.00
- Revenue This Year
- YMAB N/A
- KFS N/A
- Revenue Next Year
- YMAB $21.10
- KFS N/A
- P/E Ratio
- YMAB N/A
- KFS N/A
- Revenue Growth
- YMAB 3.38
- KFS 3.29
- 52 Week Low
- YMAB $3.86
- KFS $7.06
- 52 Week High
- YMAB $17.78
- KFS $9.58
- Technical
- Relative Strength Index (RSI)
- YMAB 47.75
- KFS 57.21
- Support Level
- YMAB $4.46
- KFS $7.28
- Resistance Level
- YMAB $5.44
- KFS $8.14
- Average True Range (ATR)
- YMAB 0.45
- KFS 0.33
- MACD
- YMAB 0.07
- KFS 0.03
- Stochastic Oscillator
- YMAB 52.53
- KFS 60.45
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.